FindTrial
Sign In

Ultrasound-Based Assessment of Poor Muscle Mass in Children with Chronic Liver Disease

Ultrasound-Based Sarcopenia Assessment in Pediatric Chronic Liver Disease: Correlation with Clinical Outcomes and Evaluation of a PELD-Sarcopenia Scoring Model - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/02/103633
Enrollment
50
Registered
2026-02-11
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K740- Hepatic fibrosis

Interventions

Intervention1: Nil: Nil

Sponsors

Dr Tryambak Samanta
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children less than or equal to 15 years of age Diagnosed with pediatric chronic liver disease Informed consent from primary caregiver

Exclusion criteria

Exclusion criteria: Hemodynamic instability Acute decompensation (overt hepatic encephalopathy, gastrointestinal bleeding)

Design outcomes

Primary

MeasureTime frame
Correlation of ultrasound-defined sarcopenia with PELD score, Infections, Hospital stay including ICU stay, Mortality over 3 year follow-upTimepoint: Continuous follow up at 4 weeks interval with additional time point at visit to hospital due to complications of the disease and new onset infections, requirement of hospital admission and death—

Secondary

MeasureTime frame
Development of a composite PELD-Sarcopenia scoring modelTimepoint: At the time of recruitment—

Countries

India

Contacts

Public ContactDr Tryambak Samanta

Medical College, Kolkata

drts.india@gmail.com08777530352

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026